Masimo (NASDAQ:MASI) issued an update on its FY22 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $4.34 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.35. The company issued revenue guidance of $1.35 billion, compared to the consensus revenue estimate of $1.35 billion.Masimo also updated its FY21 guidance to above $3.88 EPS.
MASI stock opened at $254.38 on Tuesday. The business has a fifty day moving average of $285.06 and a 200-day moving average of $276.51. The company has a market cap of $14.05 billion, a P/E ratio of 63.44 and a beta of 0.73. Masimo has a twelve month low of $205.10 and a twelve month high of $305.21.
Masimo (NASDAQ:MASI) last released its quarterly earnings data on Monday, October 25th. The medical equipment provider reported $0.94 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.03. The business had revenue of $307.40 million during the quarter, compared to the consensus estimate of $295.79 million. Masimo had a return on equity of 15.56% and a net margin of 19.23%. The firm’s revenue was up 10.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.80 earnings per share. On average, analysts predict that Masimo will post 3.88 EPS for the current year.
In other Masimo news, CEO Joe E. Kiani sold 3,429 shares of the company’s stock in a transaction that occurred on Monday, November 1st. The stock was sold at an average price of $290.08, for a total value of $994,684.32. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Joe E. Kiani sold 18,967 shares of the company’s stock in a transaction that occurred on Friday, October 29th. The shares were sold at an average price of $290.97, for a total value of $5,518,827.99. The disclosure for this sale can be found here. Insiders sold 136,389 shares of company stock valued at $40,425,338 over the last 90 days. Corporate insiders own 9.10% of the company’s stock.
Masimo Company Profile
Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories.
Featured Story: How to Invest in Marijuana Stocks
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.